Literature DB >> 23114583

Gaucher disease: insights from a rare Mendelian disorder.

Ellen Sidransky1.   

Abstract

It has become increasingly clear that "simple" recessive disorders provide unique insight into the complexities of common diseases. For years, research on Gaucher disease, a rare inherited disorder resulting from a deficiency of the lysosomal enzyme glucocerebrosidase, focused on its cell pathology and genetic basis. Clinical research showed that Gaucher disease manifests with broad phenotypic variation typical of many metabolic disorders, ranging from neonatal lethality to asymptomatic octogenarians. This clinical spectrum now overlaps with different disorders including Parkinson's disease and other Lewy body disorders, myoclonic epilepsy, and infantile neurodegenerative disorders. In fact, unraveling the factors contributing to heterogeneity in a single gene disorder may have a direct impact on studies of the pathophysiology and therapeutic options available for these more common and complex neurologic diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114583      PMCID: PMC4141347     

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  83 in total

1.  Lipid rafts mediate the synaptic localization of alpha-synuclein.

Authors:  Doris L Fortin; Matthew D Troyer; Ken Nakamura; Shin-ichiro Kubo; Malcolm D Anthony; Robert H Edwards
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

2.  Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup.

Authors:  Joseph K Park; Eduard Orvisky; Nahid Tayebi; Christine Kaneski; Mary E Lamarca; Barbara K Stubblefield; Brian M Martin; Raphael Schiffmann; Ellen Sidransky
Journal:  Pediatr Res       Date:  2003-03       Impact factor: 3.756

3.  Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.

Authors:  Ozlem Goker-Alpan; Raphael Schiffmann; Joseph K Park; Barbara K Stubblefield; Nahid Tayebi; Ellen Sidransky
Journal:  J Pediatr       Date:  2003-08       Impact factor: 4.406

4.  Gaucher's disease with Parkinson's disease: clinical and pathological aspects.

Authors:  B Bembi; S Zambito Marsala; E Sidransky; G Ciana; M Carrozzi; M Zorzon; C Martini; M Gioulis; M G Pittis; L Capus
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

5.  Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype.

Authors:  Eduard Orvisky; Joseph K Park; Mary E LaMarca; Edward I Ginns; Brian M Martin; Nahid Tayebi; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2002-08       Impact factor: 4.797

6.  Glucocerebrosidase mutations in subjects with parkinsonism.

Authors:  Alicia Lwin; Eduard Orvisky; Ozlem Goker-Alpan; Mary E LaMarca; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2004-01       Impact factor: 4.797

Review 7.  Gaucher disease: complexity in a "simple" disorder.

Authors:  Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

8.  Twin pairs showing discordance of phenotype in adult Gaucher's disease.

Authors:  R H Lachmann; I R Grant; D Halsall; T M Cox
Journal:  QJM       Date:  2004-04

9.  Gaucher disease associated with parkinsonism: four further case reports.

Authors:  Judit Várkonyi; Hanna Rosenbaum; Nicole Baumann; Jennifer J MacKenzie; Zsuzsa Simon; Judith Aharon-Peretz; Jamie M Walker; Nahid Tayebi; Ellen Sidransky
Journal:  Am J Med Genet A       Date:  2003-02-01       Impact factor: 2.802

10.  Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Authors:  N Tayebi; J Walker; B Stubblefield; E Orvisky; M E LaMarca; K Wong; H Rosenbaum; R Schiffmann; B Bembi; E Sidransky
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

View more
  49 in total

1.  Neurochemical abnormalities in patients with type 1 Gaucher disease on standard of care therapy.

Authors:  Reena V Kartha; James Joers; Marcia R Terluk; Abigail Travis; Kyle Rudser; Paul J Tuite; Neal J Weinreb; Jeanine R Jarnes; James C Cloyd; Gülin Öz
Journal:  J Inherit Metab Dis       Date:  2019-12-17       Impact factor: 4.982

Review 2.  The clinical management of Type 2 Gaucher disease.

Authors:  Karin Weiss; Ashley Gonzalez; Grisel Lopez; Leah Pedoeim; Catherine Groden; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2014-11-14       Impact factor: 4.797

3.  Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning.

Authors:  Raquel Romero; Arvind Ramanathan; Tony Yuen; Debsindhu Bhowmik; Mehr Mathew; Lubna Bashir Munshi; Seher Javaid; Madison Bloch; Daria Lizneva; Alina Rahimova; Ayesha Khan; Charit Taneja; Se-Min Kim; Li Sun; Maria I New; Shozeb Haider; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-26       Impact factor: 11.205

4.  The dipole potential correlates with lipid raft markers in the plasma membrane of living cells.

Authors:  Tamás Kovács; Gyula Batta; Florina Zákány; János Szöllősi; Peter Nagy
Journal:  J Lipid Res       Date:  2017-06-12       Impact factor: 5.922

5.  Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease.

Authors:  Pramod K Mistry; Jun Liu; Li Sun; Wei-Lien Chuang; Tony Yuen; Ruhua Yang; Ping Lu; Kate Zhang; Jianhua Li; Joan Keutzer; Agnes Stachnik; Albert Mennone; James L Boyer; Dhanpat Jain; Roscoe O Brady; Maria I New; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

6.  Jaw bones' involvement and dental features of type I and type III Gaucher disease: a radiographic study of 42 paediatric patients.

Authors:  Y S A Mohamed; M K Zayet; O M Omar; A M El-Beshlawy
Journal:  Eur Arch Paediatr Dent       Date:  2019-09-17

7.  Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells.

Authors:  Marina Siebert; Wendy Westbroek; Yu-Chi Chen; Nima Moaven; Yan Li; Arash Velayati; Maria Luiza Saraiva-Pereira; Scott E Martin; Ellen Sidransky
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

Review 8.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.

Authors:  Hagit N Baris; Ian J Cohen; Pramod K Mistry
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

Review 9.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

Review 10.  Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.

Authors:  Olive Jung; Samarjit Patnaik; Juan Marugan; Ellen Sidransky; Wendy Westbroek
Journal:  Expert Rev Proteomics       Date:  2016-04-21       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.